Reclassification of European patients' cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm

Eur J Prev Cardiol. 2015 Feb;22(2):200-2. doi: 10.1177/2047487313507680. Epub 2013 Oct 3.

Abstract

Data from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA; ClinicalTrials.gov; NCT00882336) was used to assess the proportions of patients aged 50-65 years free of diabetes and not receiving lipid-lowering therapy (LLT) considered to be at low (<1%), intermediate (1% to <5%) and high (≥5%) 10-year risk of cardiovascular mortality according to the Systematic Coronary Risk Evaluation (SCORE) algorithm and the updated algorithm that considers patients' total cholesterol and high-density lipoprotein cholesterol (HDL-C) levels as independent variables (SCORE-HDL). Of 2321 patients analysed, 19.3%, 60.7% and 20.0% were considered to be at low, intermediate and high cardiovascular risk respectively according to SCORE, and 25.7%, 57.2% and 17.1% respectively according to SCORE-HDL. Thus, there was an overall trend towards reclassification from higher to lower risk categories when SCORE-HDL was compared with SCORE.

Keywords: Cardiology; estimation techniques; risk factors.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Algorithms*
  • Body Mass Index
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / classification*
  • Cardiovascular Diseases / mortality*
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Europe / epidemiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Risk Assessment
  • Risk Factors

Substances

  • Cholesterol, HDL
  • Cholesterol

Associated data

  • ClinicalTrials.gov/NCT00882336